Dr Kathryn Wilson
Research Fellow
Department of Biological and Biomedical Sciences
Kat began her research career with a BSc (hons) in Pharmacology and Biochemistry from the University of Strathclyde, where she also undertook an MRes in Drug Delivery, developing nanoparticle delivery systems for the treatment of type 2 diabetes mellitus. Following this, Kat undertook an MSc in Cardiovascular Biology and subsequently a PhD from the University of Edinburgh investigating the role of glucocorticoids in Danio rerio (zebrafish) cardiovascular development.
Kat began her post-doctoral research career by joining the Scottish Pulmonary Vascular Unit (SPVU) at the University of Glasgow with her research focusing on mitogen-activated protein kinases (MAPK) - specifically ASK1 - as a novel therapeutic target for the treatment of pulmonary arterial hypertension. From here, Kat was able to secure a highly sought-after British Heart Foundation Basic Science Immediate post-doctoral fellowship to investigate the role of IL-33/ST2 signalling in the cardiac and vascular remodelling associated with pulmonary arterial hypertension.
Kat has continued her association with the SPVU and began her role as a research fellow at Glasgow Caledonian University in 2021. Her research interests include cardiovascular fibroblasts, fibrosis and cardiac remodelling, molecular signalling, the development of novel in vitro models and the investigation of new therapeutic targets for pulmonary arterial hypertension.
Outside the lab, Kat is a keen participant in public engagement, outreach and STEM activities and is also co-chair of the SHLS ECR Network. She is a member of the BSCR, PVRI and Biochemical Society. Further details regarding Dr Wilson’s research and publication history can be found in her research profile.